CUV 0.00% $14.30 clinuvel pharmaceuticals limited

Epitan is still on track, sellers are still taking profits from...

  1. 14,434 Posts.
    lightbulb Created with Sketch. 609
    Epitan is still on track, sellers are still taking profits from the placement issued at 51c from capital raising. They will evetually dry up and buyers will accumulate. The company have NO DEBTS and NO BORROWINGS, report sounds positive in achieving their targets
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.